Scientists discover that the CD74 protein could predict the effectiveness of immunotherapy, advancing colon cancer treatment.

With minimal blood loss and scarring, and faster recovery period, robotic surgeries are becoming game changers in the ...

A group of 18 colorectal cancer patients experienced complete remission after taking the experimental drug dostarlimab for ...

The results could sway U.S. regulators to convert Braftovi’s accelerated clearance in colorectal tumors into a full approval ...

Pfizer PFE announced positive top-line results from the progression-free survival (PFS) analysis of a late-stage study of its ...

Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...

Research that has not yet been peer-reviewed shows the newest blood test is more than 80% accurate in detecting colon cancer ...

Less than two months after an accelerated approval from the FDA, a drug combination featuring Pfizer’s Braftovi has turned in ...

A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...

Pfizer's Braftovi combination showed significant survival benefits in a Phase 3 study for BRAF V600E-mutant metastatic ...

About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of ...

Getting regular checkups and colon cancer screening is the best way to prevent colorectal cancer. The US Preventive Services Task Force and the American Cancer Society both recommend that people ...